臨牀消化器内科 Vol.32 No.10(2-1)


特集名 腸内細菌と臨床
題名 腸内細菌と他疾患(1)腸内細菌と精神疾患
発刊年月 2017年 09月
著者 金子 宏 星ヶ丘マタニティ病院内科・心療内科
【 要旨 】 19世紀末には腸で発生した毒素がうつ病,不安,精神病につながるという「自家中毒」が信じられていた.生体は有害なストレスにさらされたとき,視床下部‒下垂体‒副腎軸と交感神経系を活性化させて恒常性を維持させる.無菌マウスでは前者が亢進し,正常マウスの腸内細菌移植で正常化するとの本邦からの重要な発見もあり,脳‒腸‒腸内細菌軸がクローズアップされている.その流れのなかで腸内細菌と精神疾患の関係が明らかになりつつある.とりわけ,腸内細菌とうつ病・自閉症の臨床研究が進んでいる.ともに多彩な消化器症状が高率にみられるが,まさに脳‒腸‒腸内細菌軸研究の先端分野となっている.
Theme Roles and Importance of Microbiota in Clinical Medicine
Title Gut Microbiota and Psychiatric Illness
Author Hiroshi Kaneko Division of Internal & Psychosomatic Internal Medicine, Hoshigaoka Maternity Hospital
[ Summary ] In the late 19th century, scientists believed that certain toxins generated in the gut could trigger depression, anxiety, and psychiatric diseases in a process known as 'autointoxication.' When a living body is exposed to harmful stressor(s), it activates the hypothalamic‒pituitary‒adrenal (HPA) axis and the sympathetic system in order to maintain its homeostasis. In 2004, Japanese scientists made the important observation that the HPA axis was activated in germ‒free mice and this hyperactivation was normalized after transplantation of normal gut microbiota. This discovery attracted attention to the 'brain‒gut‒gut microbiota axis'. Subsequent studies have shed more light on the relationship between gut microbiota and psychiatric illness. In particular, the clinical correlation between gut microbiota and depression/autism has been extensively investigated. It has been reported that patients with depression/autism have higher rates of various gastrointestinal symptoms. Studies on psychiatric disease and gut microbiota should be a priority in 'brain‒gut‒gut microbiota axis' research.
戻る